Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
720707-93-7
32405-88-2
1457483-77-0 | 2-[(2-Chloropyridin-4-yl)methyl]isoindole-1,3-dione | AA00HXDQ | MFCD17477184
1498333-87-1 | (4-(Pyridin-2-yl)phenyl)methanamine HCl | AA00HXO0 | MFCD27923416
1523530-25-7 | (3R,4R)-4-Fluoro-3-pyrrolidinol hcl | AA00HXW1 | MFCD27978542
153504-79-1 | 5-Bromo-7-(trifluoromethyl)-1,4-dihydroquinoxaline-2,3-dione | AA00HY26 | MFCD00829051
1554504-76-5 | 3-(2-Methoxypyridin-4-yl)benzoic acid | AA00HY94 | MFCD25242237
1595285-01-0 | 2-(Pyrrolidin-1-yl)thiazol-5-ylboronic acid pinacol ester | AA00HYGR | MFCD13182299
1620108-43-1 | Potassium (4-chloro-2-methylphenyl)trifluoroborate | AA00HYMQ | MFCD09993378
16398-16-6 | 2-Nitrodibenzo[b,f][1,4]oxazepin-11(10h)-one | AA00HYZS | MFCD00478144
168618-35-7 | Methyl 3-(pyrazol-1-yl)benzoate | AA00HZ5Y | MFCD20441358
171032-74-9 | 1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-D-glucopyranose | AA00HZFX | MFCD07778213